128 related articles for article (PubMed ID: 14646678)
1. Cost of glaucoma in Canada: analyses based on visual field and physician's assessment.
Iskedjian M; Walker J; Vicente C; Trope GE; Buys Y; Einarson TR; Covert D
J Glaucoma; 2003 Dec; 12(6):456-62. PubMed ID: 14646678
[TBL] [Abstract][Full Text] [Related]
2. Association between mean intraocular pressure, disease stability and cost of treating glaucoma in Canada.
Vicente C; Walker J; Buys Y; Einarson TR; Covert D; Iskedjian M
Curr Med Res Opin; 2004 Aug; 20(8):1245-51. PubMed ID: 15324527
[TBL] [Abstract][Full Text] [Related]
3. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany.
Lorenz K; Wolfram C; Breitscheidel L; Shlaen M; Verboven Y; Pfeiffer N
Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2019-28. PubMed ID: 23624617
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Resource Use and Costs of Caring for Patients With Exfoliation Syndrome Glaucoma Versus Primary Open-Angle Glaucoma.
Rathi S; Andrews C; Greenfield DS; Stein JD
Am J Ophthalmol; 2019 Apr; 200():100-109. PubMed ID: 30629910
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
Lee PP; Walt JG; Doyle JJ; Kotak SV; Evans SJ; Budenz DL; Chen PP; Coleman AL; Feldman RM; Jampel HD; Katz LJ; Mills RP; Myers JS; Noecker RJ; Piltz-Seymour JR; Ritch RR; Schacknow PN; Serle JB; Trick GL
Arch Ophthalmol; 2006 Jan; 124(1):12-9. PubMed ID: 16401779
[TBL] [Abstract][Full Text] [Related]
6. Resource use and costs for a glaucoma screening program in Austria: an 8-year review: a cost-consequence analysis based on the Salzburg-Moorfields Collaborative Glaucoma Study.
Hitzl W; Ortner C; Hornykewycz K; Grabner G; Reitsamer HA
Eur J Ophthalmol; 2006; 16(1):92-9. PubMed ID: 16496251
[TBL] [Abstract][Full Text] [Related]
7. Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease.
Lee PP; Kelly SP; Mills RP; Traverso CE; Walt JG; Doyle JJ; Katz LM; Siegartel LR;
J Glaucoma; 2007 Aug; 16(5):471-8. PubMed ID: 17700290
[TBL] [Abstract][Full Text] [Related]
8. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study.
Gieser DK; Tracy Williams R; O'Connell W; Pasquale LR; Rosenthal BP; Walt JG; Katz LM; Siegartel LR; Wang L; Rosenblatt LC; Stern LS; Doyle JJ
J Glaucoma; 2006 Oct; 15(5):419-25. PubMed ID: 16988605
[TBL] [Abstract][Full Text] [Related]
9. Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?
Hagman J
Acta Ophthalmol; 2013 May; 91 Thesis 3():1-47. PubMed ID: 23621767
[TBL] [Abstract][Full Text] [Related]
10. Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1.
Aptel F; Aryal-Charles N; Giraud JM; El Chehab H; Delbarre M; Chiquet C; Romanet JP; Renard JP
Acta Ophthalmol; 2015 Dec; 93(8):e615-20. PubMed ID: 26095771
[TBL] [Abstract][Full Text] [Related]
11. [An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients].
Rouland JF; Peigne G; Sellem E; Renard JP; Williamson W; Filippi JM; Cohn H; Hamard P; Abellan P; Chagnon A; Malet F; Haye I
J Fr Ophtalmol; 2001 Mar; 24(3):233-43. PubMed ID: 11285438
[TBL] [Abstract][Full Text] [Related]
12. Association between corneal thickness, mean intraocular pressure, disease stability and severity, and cost of treatment in glaucoma: a Canadian analysis.
Walker JH; Buys Y; Trope G; Vicente C; Einarson TR; Covert D; Iskedjian M
Curr Med Res Opin; 2005 Apr; 21(4):489-94. PubMed ID: 15899096
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
14. Association of serum uric acid levels with primary open-angle glaucoma: a 5-year case-control study.
Li S; Shao M; Li D; Tang B; Cao W; Sun X
Acta Ophthalmol; 2019 May; 97(3):e356-e363. PubMed ID: 29673085
[TBL] [Abstract][Full Text] [Related]
15. Patterns of care for open-angle glaucoma in managed care.
Fremont AM; Lee PP; Mangione CM; Kapur K; Adams JL; Wickstrom SL; Escarce JJ
Arch Ophthalmol; 2003 Jun; 121(6):777-83. PubMed ID: 12796247
[TBL] [Abstract][Full Text] [Related]
16. Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States.
Kobelt-Nguyen G; Gerdtham UG; Alm A
J Glaucoma; 1998 Apr; 7(2):95-104. PubMed ID: 9559495
[TBL] [Abstract][Full Text] [Related]
17. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D; Curry A; Evans SJ
Acta Ophthalmol Scand; 2006 Feb; 84(1):74-83. PubMed ID: 16445443
[TBL] [Abstract][Full Text] [Related]
18. Long-term filtration and visual field outcomes after primary glaucoma triple procedure with and without mitomycin-C.
Shin DH; Iskander NG; Ahee JA; Singal IP; Kim C; Hughes BA; Eliassi-Rad B; Kim YY
Ophthalmology; 2002 Sep; 109(9):1607-11. PubMed ID: 12208706
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada.
Patel V; Ahmed I; Podbielski D; Falvey H; Murray J; Goeree R
J Med Econ; 2019 Apr; 22(4):390-401. PubMed ID: 30663456
[TBL] [Abstract][Full Text] [Related]
20. SHORT TERM EVALUATION OF PERIMETRIC PROGRESSION IN PATIENTS WITH OPEN ANGLE GLAUCOMA AND DIABETES.
Pantalon A; Feraru C; ChiseliĊ£a D
Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):83-9. PubMed ID: 27125077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
